Synthesis, characterization, X-ray crystal structure and in vitro antitumour activity of sodium bis(2-(3′,6′,9′ -trioxadecyl)-1,2-dicarba-closo-dodecaborane-1-carboxylato)triphenylstannate

Applied Organometallic Chemistry

Volumn 18, Issue 4, 2004, Pages 191-194

  Bregadze, V I ^a   Glazun, S A ^a   Petrovskii, P V ^a   Starikova, Z A ^a   Buyanovskaya, A G ^a   Takazova, R U ^a   Gielen, M ^b   De Vos, D ^c   Kemmer, M ^b   Biesemans, M ^b   Willem, R ^b  

^a A N NESMEYANOV INSTITUTE OF ORGANOELEMENT COMPOUNDS   (Russian Federation)

^b VRIJE UNIVERSITEIT BRUSSEL   (Belgium)

^c TEVA Pharmachemie   (Netherlands)

Author keywords

Antitumour activity; Crystal structure; Organotin carboranecarboxylate; Synthesis

Indexed keywords

BICARBONATE; CARBOPLATIN; CARBORANE DERIVATIVE; CARBOXYLIC ACID DERIVATIVE; CISPLATIN; DOXORUBICIN; FLUOROURACIL; METHOTREXATE; ORGANOTIN COMPOUND; SODIUM BIS[2 (3',6',9' TRIOXADECYL) 1,2 DICARBA CLOSO DODECABORANE 1 CARBOXYLATO]TRIPHENYLSTANNATE; SODIUM DERIVATIVE; TRIPHENYLTIN CHLORIDE; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; ARTICLE; BREAST CANCER; COLON CANCER; CONCENTRATION RESPONSE; CONTROLLED STUDY; CRYSTAL STRUCTURE; DRUG SYNTHESIS; HUMAN; HUMAN CELL; KIDNEY CANCER; LUNG NON SMALL CELL CANCER; MELANOMA; OVARY CANCER; STRUCTURE ACTIVITY RELATION; TUMOR CELL LINE; X RAY CRYSTALLOGRAPHY; X RAY DIFFRACTION;

EID: 12144288302     PISSN: 02682605     EISSN: None     Source Type: Journal    
DOI: 10.1002/aoc.599     Document Type: Article

References (22)

1. Gielen M. Appl. Organometal. Chem. 2002; 16: 481.
2. Bregadze VI. Chem. Rev. 1992; 92: 209.
3. Gielen M, Kayser F, Zhidkova OB, Kampel VTs, Bregadze VI, de Vos D, Biesemans M, Mahieu B, Willem R. Metal-Based Drugs 1995; 2: 37.
4. Gielen M, Bouhdid A, Willem R, Bregadze VI, Ermanson LV, Tiekink ERT. J. Organometal. Chem. 1995; 501: 277.
5. Tiekink ERT, Gielen M, Bouhdid A, Willem R, Bregadze VI, Ermanson LV, Glazun SA. Metal-Based Drugs 1997; 4: 75.
6. Bregadze VI, Glazun SA, Petrovskii PV, Starikova ZA, Rochev VA, Dalil H, Biesemans M, Willem R, Gielen M, de Vos D. Appl. Organometal. Chem. 2003; 17: 453.
7. Kemmer M, Gielen M, Biesemans M, de Vos D, Willem R. Metal-Based Drugs 1998; 5: 189.
8. Kemmer M, Ghys L, Gielen M, Biesemans M, Tiekink ERT, Willem R. J. Organometal. Chem. 1999; 582: 195.
9. Allen FH, Kennard O. Chem. Des. Automat. News 1993; 8: 1, 31.
10. Ng SW, Das VGK, Gielen M, Tiekink ERT. Appl. Organometal. Chem. 1992; 6: 19.
11. Ng SW, Das VGK, Gielen M. Appl. Organometal. Chem. 1992; 6: 489.
12. Willem R, Biesemans M, Kayser F, Bouâlam M, Gielen M. Inorg. Chim. Acta 1992; 197: 25.
13. Willem R, Biesemans M, Bouâlam M, Delmotte A, El Khloufi A, Gielen M. Appl. Organometal. Chem. 1993; 7: 311.
14. Semioshkin AA, Ptashits GM, Glazun SA, Kachala VV, Petrovskii PV, Bregadze VI. Mendeleev Commun. 2000; 118.
15. Mason J. Multinuclear NMR. Plenum Press: New York, 1987; 627.
16. Bouâlam M, Willem R, Biesemans M, Mahieu B, Meunier-Piret J, Gielen M. Main Group Met. Chem. 1991; 14: 41.
17. Gel'man NE (ed.). Methods of Quality Organic Elemental Micro-analysis. Khimia: Moscow, 1987; 293.
18. DeVita Jr VT, Hellman S, Rosenberg SA (eds). Cancer: Principles and Practice of Oncology, 5th edn. Lippincott-Raven: Philadelphia, 1997.
19. Kepers YP, Peters GJ, Van Ark-Otte J, Winograd B, Pinedo HM. Eur. J. Cancer 1991; 27: 897.
20. SAINT V5.00, Area detector control and integration software, Bruker AXS Inc., Madison,WI-53719, USA, 1998.
21. Sheldrick GM. SADABS v.2.01, Bruker/Siemens area detector absorption correction program. Bruker AXS, Madison, WI, USA, 1998.
22. Sheldrick GM. SHELXTL v. 5.10, Structure determination software suite. Bruker AXS, Madison, WI, USA, 1998.